Simplex Trading, LLC Verastem, Inc. Transaction History

Simplex Trading, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.39 - $0.71 $6,238 - $11,356	15,995 New	15,995 $6,000
Q3 2021 Oct 28, 2021	SELL	$2.54 - $4.07 $213 - $341	-84 Reduced 11.51%	646 $2,000
Q2 2021 Aug 12, 2021	BUY	$2.57 - $4.85 $1,876 - $3,540	730 New	730 $2,000
Q1 2021 Apr 26, 2021	SELL	$1.9 - $2.82 $17,880 - $26,539	-9,411 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$1.15 - $2.4 $39,643 - $82,735	-34,473 Reduced 78.55%	9,411 $20,000
Q3 2020 Oct 14, 2020	BUY	$1.11 - $1.68 $8,595 - $13,009	7,744 Added 21.43%	43,884 $53,000
Q2 2020 Jul 13, 2020	BUY	$1.69 - $4.2 $60,569 - $150,528	35,840 Added 11946.67%	36,140 $62,000
Q1 2020 Apr 29, 2020	SELL	$1.26 - $3.38 $33,424 - $89,661	-26,527 Reduced 98.88%	300 $0
Q4 2019 Feb 05, 2020	BUY	$0.86 - $1.44 $14,423 - $24,151	16,772 Added 166.8%	26,827 $35,000
Q3 2019 Oct 15, 2019	BUY	$1.21 - $1.59 $12,166 - $15,987	10,055 New	10,055 $12,000
Q1 2019 Apr 18, 2019	SELL	$2.79 - $4.09 $51,213 - $75,076	-18,356 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$3.23 - $7.01 $24,728 - $53,668	-7,656 Reduced 29.43%	18,356 $61,000
Q3 2018 Oct 23, 2018	SELL	$6.86 - $9.97 $486,312 - $706,783	-70,891 Reduced 73.16%	26,012 $188,000
Q2 2018 Jul 30, 2018	BUY	$2.88 - $8.67 $279,080 - $840,149	96,903 New	96,903 $666,000
Q1 2018 Apr 26, 2018	SELL	$2.92 - $3.81 $16,906 - $22,059	-5,790 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$2.99 - $4.85 $24,383 - $39,551	-8,155 Reduced 58.48%	5,790 $17,000
Q3 2017 Oct 25, 2017	BUY	$3.01 - $5.41 $41,974 - $75,442	13,945	13,945 $65,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.